|
|
||||||||
The Journal of Immunology, Vol 157, Issue 4 1406-1414, Copyright © 1996 by American Association of Immunologists
ARTICLES |
FD Finkelman, A Lees, R Birnbaum, WC Gause and SC Morris
Department of Medicine, University of Cincinnati College of Medicine, OH 45267, USA.
Dendritic cells (DC) are unmatched among APCs in their ability to bind, process, and present Ag. Presentation by such potent APCs, if always immunogenic and never tolerogenic, might stimulate pathogenic autoimmune responses. To determine whether Ag presentation by DC can induce tolerance, mice were injected with a rat IgG2b anti-splenic DC mAb, 33D1, and challenged 13 to 28 days later with a stimulatory rat IgG2b mAb. Injection of mice with 1 ng/100 micrograms of 33D1 rarely induced an anti-rat IgG2b Ab response and, in most mice, induced rat IgG2b-specific T cell and B cell tolerance. Tolerant mice had decreased ability to secrete Ab and make both type 1 and type 2 cytokine mRNA and protein in response to immunization with rat IgG2b. 33D1 was 100- to 1000-fold more potent as a tolerogen than an isotype-matched control rat IgG2b mAb. Injecting mice with aggregated 33D1, 33D1 plus anti-IgD mAb, or 33D1 plus IL-1 induced an IgG1 anti-rat IgG2b Ab response rather than tolerance. IL-1 injected 3 days after 33D1 still induced an Ab response rather than tolerance. Not all anti-DC mAbs are tolerogenic. Injection of a DC-specific hamster anti-CD11c mAb (N418) stimulates an IgG anti-hamster response, and injection of 33D1 plus N418 stimulates both anti-hamster and anti-rat IgG2b responses. These observations indicate that DCs can present Ag in either a tolerogenic or stimulatory manner and suggest that inflammatory stimuli can convert an otherwise tolerogenic signal to a stimulatory signal.
This article has been cited by other articles:
![]() |
O. Jin, S. Kavikondala, L. Sun, R. Fu, M.-Y. Mok, A. Chan, J. Yeung, and C.-S. Lau Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression Lupus, July 1, 2008; 17(7): 654 - 662. [Abstract] [PDF] |
||||
![]() |
S.-E. Lamhamedi-Cherradi, R. E. Martin, T. Ito, F. Kheradmand, D. B. Corry, Y.-J. Liu, and M. Moyle Fungal Proteases Induce Th2 Polarization through Limited Dendritic Cell Maturation and Reduced Production of IL-12 J. Immunol., May 1, 2008; 180(9): 6000 - 6009. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Santos, K. E. Draves, M. Boton, P. K. Grewal, J. D. Marth, and E. A. Clark Dendritic Cell-Dependent Inhibition of B Cell Proliferation Requires CD22 J. Immunol., April 1, 2008; 180(7): 4561 - 4569. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cools, P. Ponsaerts, V. F. I. Van Tendeloo, and Z. N. Berneman Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells J. Leukoc. Biol., December 1, 2007; 82(6): 1365 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Ashour and T. M. Seif The role of B cells in the induction of peripheral T cell tolerance J. Leukoc. Biol., November 1, 2007; 82(5): 1033 - 1039. [Full Text] [PDF] |
||||
![]() |
Y.-X. Chen, K. Man, G. S. Ling, Y. Chen, B.-S. Sun, Q. Cheng, O. H. Wong, C.-K. Lo, I. O.-L. Ng, L. C. Chan, et al. A Crucial Role for Dendritic Cell (DC) IL-10 in Inhibiting Successful DC-Based Immunotherapy: Superior Antitumor Immunity against Hepatocellular Carcinoma Evoked by DC Devoid of IL-10 J. Immunol., November 1, 2007; 179(9): 6009 - 6015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Hagymasi, A. M. Slaiby, M. A. Mihalyo, H. Z. Qui, D. J. Zammit, L. Lefrancois, and A. J. Adler Steady State Dendritic Cells Present Parenchymal Self-Antigen and Contribute to, but Are Not Essential for, Tolerization of Naive and Th1 Effector CD4 Cells J. Immunol., August 1, 2007; 179(3): 1524 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Geyeregger, M. Zeyda, W. Bauer, E. Kriehuber, M. D. Saemann, G. J. Zlabinger, D. Maurer, and T. M. Stulnig Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin Blood, May 15, 2007; 109(10): 4288 - 4295. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Aspord, A. Pedroza-Gonzalez, M. Gallegos, S. Tindle, E. C. Burton, D. Su, F. Marches, J. Banchereau, and A. K. Palucka Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development J. Exp. Med., May 14, 2007; 204(5): 1037 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. McKenzie, P. R. Taylor, R. J. Stillion, A. D. Lucas, J. Harris, S. Gordon, and L. Martinez-Pomares Mannose Receptor Expression and Function Define a New Population of Murine Dendritic Cells J. Immunol., April 15, 2007; 178(8): 4975 - 4983. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Carter, C. Thompson, D. M. Reid, S. Y. C. Wong, and D. F. Tough Preferential Induction of CD4+ T Cell Responses through In Vivo Targeting of Antigen to Dendritic Cell-Associated C-Type Lectin-1 J. Immunol., August 15, 2006; 177(4): 2276 - 2284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grdic, L. Ekman, K. Schon, K. Lindgren, J. Mattsson, K.-E. Magnusson, P. Ricciardi-Castagnoli, and N. Lycke Splenic Marginal Zone Dendritic Cells Mediate the Cholera Toxin Adjuvant Effect: Dependence on the ADP-Ribosyltransferase Activity of the Holotoxin J. Immunol., October 15, 2005; 175(8): 5192 - 5202. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Steptoe, J. M. Ritchie, L. K. Jones, and L. C. Harrison Autoimmune Diabetes Is Suppressed by Transfer of Proinsulin-Encoding Gr-1+ Myeloid Progenitor Cells That Differentiate In Vivo Into Resting Dendritic Cells Diabetes, February 1, 2005; 54(2): 434 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. MacPHERSON, S. MILLING, U. YRLID, L. COUSINS, E. TURNBULL, and F.-P. HUANG Uptake of Antigens from the Intestine by Dendritic Cells Ann. N.Y. Acad. Sci., December 1, 2004; 1029(1): 75 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. LYCKE ADP-Ribosylating Bacterial Enzymes for the Targeted Control of Mucosal Tolerance and Immunity Ann. N.Y. Acad. Sci., December 1, 2004; 1029(1): 193 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Zang, S. M Skinner, R. R Robinson, S. Li, V. M Rivera, G. J Hutton, and J. Z Zhang Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis Multiple Sclerosis, October 1, 2004; 10(5): 499 - 506. [Abstract] [PDF] |
||||
![]() |
M. Galgani, V. De Rosa, S. De Simone, A. Leonardi, U. D'Oro, G. Napolitani, A. M. Masci, S. Zappacosta, and L. Racioppi Cyclic AMP Modulates the Functional Plasticity of Immature Dendritic Cells by Inhibiting Src-like Kinases through Protein Kinase A-mediated Signaling J. Biol. Chem., July 30, 2004; 279(31): 32507 - 32514. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Wilson, D. El-Sukkari, and J. A. Villadangos Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis Blood, March 15, 2004; 103(6): 2187 - 2195. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Wilson, D. El-Sukkari, G. T. Belz, C. M. Smith, R. J. Steptoe, W. R. Heath, K. Shortman, and J. A. Villadangos Most lymphoid organ dendritic cell types are phenotypically and functionally immature Blood, September 15, 2003; 102(6): 2187 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Orsini, A. Guarini, S. Chiaretti, F. R. Mauro, and R. Foa The Circulating Dendritic Cell Compartment in Patients with Chronic Lymphocytic Leukemia Is Severely Defective and Unable to Stimulate an Effective T-Cell Response Cancer Res., August 1, 2003; 63(15): 4497 - 4506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. BANCHEREAU, S. PACZESNY, P. BLANCO, L. BENNETT, V. PASCUAL, J. FAY, and A. K. PALUCKA Dendritic Cells: Controllers of the Immune System and a New Promise for Immunotherapy Ann. N.Y. Acad. Sci., April 1, 2003; 987(1): 180 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. de Gruijl, S. A. Luykx-de Bakker, B. W. Tillman, A. J. M. van den Eertwegh, J. Buter, S. M. Lougheed, G. J. van der Bij, A. M. Safer, H. J. Haisma, D. T. Curiel, et al. Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors J. Immunol., November 1, 2002; 169(9): 5322 - 5331. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Geissmann, M.C. Dieu-Nosjean, C. Dezutter, J. Valladeau, S. Kayal, M. Leborgne, N. Brousse, S. Saeland, and J. Davoust Accumulation of Immature Langerhans Cells in Human Lymph Nodes Draining Chronically Inflamed Skin J. Exp. Med., August 19, 2002; 196(4): 417 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuchiya, K. Chida, T. Suda, E. E. Schneeberger, and H. Nakamura Dendritic Cell Involvement in Pulmonary Granuloma Formation Elicited by Bacillus Calmette-Guerin in Rats Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1640 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Woltman, C. Massacrier, J. W. de Fijter, C. Caux, and C. van Kooten Corticosteroids Prevent Generation of CD34+-Derived Dermal Dendritic Cells But Do Not Inhibit Langerhans Cell Development J. Immunol., June 15, 2002; 168(12): 6181 - 6188. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Higgins, M. A. Mihalyo, P. W. McGary, and A. J. Adler CD4 Cell Priming and Tolerization Are Differentially Programmed by APCs upon Initial Engagement J. Immunol., June 1, 2002; 168(11): 5573 - 5581. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gregori, N. Giarratana, S. Smiroldo, M. Uskokovic, and L. Adorini A 1{alpha},25-Dihydroxyvitamin D3 Analog Enhances Regulatory T-Cells and Arrests Autoimmune Diabetes in NOD Mice Diabetes, May 1, 2002; 51(5): 1367 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. von Bergwelt-Baildon, R. H. Vonderheide, B. Maecker, N. Hirano, K. S. Anderson, M. O. Butler, Z. Xia, W. Y. Zeng, K. W. Wucherpfennig, L. M. Nadler, et al. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application Blood, May 1, 2002; 99(9): 3319 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hawiger, K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, M. Rivera, J. V. Ravetch, R. M. Steinman, and M. C. Nussenzweig Dendritic Cells Induce Peripheral T Cell Unresponsiveness Under Steady State Conditions In Vivo J. Exp. Med., September 17, 2001; 194(6): 769 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tian, D. Zekzer, L. Hanssen, Y. Lu, A. Olcott, and D. L. Kaufman Lipopolysaccharide-Activated B Cells Down-Regulate Th1 Immunity and Prevent Autoimmune Diabetes in Nonobese Diabetic Mice J. Immunol., July 15, 2001; 167(2): 1081 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. d. C. Bittencourt, S. Perruche, E. Contassot, S. Fresnay, M.-H. Baron, R. Angonin, F. Aubin, P. Herve, P. Tiberghien, and P. Saas Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers Blood, July 1, 2001; 98(1): 224 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Gonnella, H. P. Waldner, and H. L. Weiner B Cell-Deficient ({micro}MT) Mice Have Alterations in the Cytokine Microenvironment of the Gut-Associated Lymphoid Tissue (GALT) and a Defect in the Low Dose Mechanism of Oral Tolerance J. Immunol., April 1, 2001; 166(7): 4456 - 4464. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, S. Kim, C. H. Evans, S. C. Ghivizzani, T. Oligino, and P. D. Robbins Effective Treatment of Established Murine Collagen-Induced Arthritis by Systemic Administration of Dendritic Cells Genetically Modified to Express IL-4 J. Immunol., March 1, 2001; 166(5): 3499 - 3505. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jilek, C. Barbey, F. Spertini, and B. Corthesy Antigen-Independent Suppression of the Allergic Immune Response to Bee Venom Phospholipase A2 by DNA Vaccination in CBA/J Mice J. Immunol., March 1, 2001; 166(5): 3612 - 3621. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Marelli-Berg, D. Scott, I. Bartok, E. Peek, J. Dyson, and R. I. Lechler Activated Murine Endothelial Cells Have Reduced Immunogenicity for CD8+ T Cells: A Mechanism of Immunoregulation? J. Immunol., October 15, 2000; 165(8): 4182 - 4189. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. SMITH, A. D. EATON, L. M. FINLAYSON, and P. GARSIDE Oral Tolerance Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): S175 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Schmitt and S. E. Ullrich Exposure to Ultraviolet Radiation Causes Dendritic Cells/Macrophages to Secrete Immune-Suppressive IL-12p40 Homodimers J. Immunol., September 15, 2000; 165(6): 3162 - 3167. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Wang, M. Kutsche, G. DiSciullo, M. Schachner, and S. A. Bogen Selective Malformation of the Splenic White Pulp Border in L1-Deficient Mice J. Immunol., September 1, 2000; 165(5): 2465 - 2473. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Penna and L. Adorini 1{alpha},25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic Cells Leading to Impaired Alloreactive T Cell Activation J. Immunol., March 1, 2000; 164(5): 2405 - 2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Morris, W. C. Gause, and F. D. Finkelman IL-4 Suppression of In Vivo T Cell Activation and Antibody Production J. Immunol., February 15, 2000; 164(4): 1734 - 1740. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-P. Huang, N. Platt, M. Wykes, J. R. Major, T. J. Powell, C. D. Jenkins, and G. G. MacPherson A Discrete Subpopulation of Dendritic Cells Transports Apoptotic Intestinal Epithelial Cells to T Cell Areas of Mesenteric Lymph Nodes J. Exp. Med., February 7, 2000; 191(3): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, M. N. Griffiths, D. R. Burton, and P. Ghazal Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization PNAS, January 18, 2000; 97(2): 847 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Finkelman and S. C. Morris Development of an assay to measure in vivo cytokine production in the mouse Int. Immunol., November 1, 1999; 11(11): 1811 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chung, S.-Y. Chang, and C.-Y. Kang Kinetic Analysis of Oral Tolerance: Memory Lymphocytes Are Refractory to Oral Tolerance J. Immunol., October 1, 1999; 163(7): 3692 - 3698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Todryk, A. A. Melcher, N. Hardwick, E. Linardakis, A. Bateman, M. P. Colombo, A. Stoppacciaro, and R. G. Vile Heat Shock Protein 70 Induced During Tumor Cell Killing Induces Th1 Cytokines and Targets Immature Dendritic Cell Precursors to Enhance Antigen Uptake J. Immunol., August 1, 1999; 163(3): 1398 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-g. Zhang, X. Su, D. Liu, W. Liu, P. Yang, Z. Wang, C. K. Edwards, H. Bluethmann, J. D. Mountz, and T. Zhou Induction of Specific T Cell Tolerance by Fas Ligand- Expressing Antigen-Presenting Cells J. Immunol., February 1, 1999; 162(3): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Porgador, H. F. Staats, Y. Itoh, and B. L. Kelsall Intranasal Immunization with Cytotoxic T-Lymphocyte Epitope Peptide and Mucosal Adjuvant Cholera Toxin: Selective Augmentation of Peptide-Presenting Dendritic Cells in Nasal Mucosa-Associated Lymphoid Tissue Infect. Immun., December 1, 1998; 66(12): 5876 - 5881. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Silverman, J. V. Nayak, K. Warnatz, F. F. Hajjar, S. Cary, H. Tighe, and V. E. Curtiss The Dual Phases of the Response to Neonatal Exposure to a VH Family-Restricted Staphylococcal B Cell Superantigen J. Immunol., November 15, 1998; 161(10): 5720 - 5732. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takahashi, M. C. Honeyman, and L. C. Harrison Impaired Yield, Phenotype, and Function of Monocyte-Derived Dendritic Cells in Humans at Risk for Insulin-Dependent Diabetes J. Immunol., September 1, 1998; 161(5): 2629 - 2635. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Liu, M. Zhang, C. Jenkins, and G. G. MacPherson Dendritic Cell Heterogeneity In Vivo: Two Functionally Different Dendritic Cell Populations in Rat Intestinal Lymph Can Be Distinguished by CD4 Expression J. Immunol., August 1, 1998; 161(3): 1146 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Viney, A. M. Mowat, J. M. O'Malley, E. Williamson, and N. A. Fanger Expanding Dendritic Cells In Vivo Enhances the Induction of Oral Tolerance J. Immunol., June 15, 1998; 160(12): 5815 - 5825. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Adler, D. W. Marsh, G. S. Yochum, J. L. Guzzo, A. Nigam, W. G. Nelson, and D. M. Pardoll CD4+ T Cell Tolerance to Parenchymal Self-Antigens Requires Presentation by Bone Marrow-derived Antigen-presenting Cells J. Exp. Med., May 18, 1998; 187(10): 1555 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. M. Toes, E. I. H. van der Voort, S. P. Schoenberger, J. W. Drijfhout, L. van Bloois, G. Storm, W. M. Kast, R. Offringa, and C. J. M. Melief Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells J. Immunol., May 1, 1998; 160(9): 4449 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krasteva, J. Kehren, F. Horand, H. Akiba, G. Choquet, M.-T. Ducluzeau, R. Tedone, J.-L. Garrigue, D. Kaiserlian, and J.-F. Nicolas Dual Role of Dendritic Cells in the Induction and Down-Regulation of Antigen-Specific Cutaneous Inflammation J. Immunol., February 1, 1998; 160(3): 1181 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N.J. Hart Dendritic Cells: Unique Leukocyte Populations Which Control the Primary Immune Response Blood, November 1, 1997; 90(9): 3245 - 3287. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |